BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

GlucoTrack Inc. (NASDAQ:GCTK)

6 posts

Biotech NewsShould You Buy GlucoTrack (GCTK) Shares Today?

  • BioTech Health X
  • April 5, 2026
We recently published our article Top 10 Biotech Stocks That Could Deliver 1,000% Returns. In this piece, we…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 10 Biotech Stocks That Could Deliver 1,000% Returns

  • BioTech Health X
  • April 2, 2026
In this article, will take a look at the Top 10 Biotech Stocks That Could Deliver 1,000% Returns.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 10 Biotech Stocks to Watch Now

  • BioTech Health X
  • April 2, 2026
In this article, will take a look at the Top 10 Biotech Stocks to Watch Now. The biotechnology…
0 Shares
0
0
0
0
0
0
0

Biotech NewsGlucoTrack (GCTK) Posts $9.6M Cash Reserves

  • BioTech Health X
  • September 12, 2025
GlucoTrack Inc. (NASDAQ:GCTK) is a pioneering medical device company committed to transforming the way diabetes is managed worldwide.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSmart Investors Are Loading Up on GlucoTrack (GCTK) Before Q3 Milestones

  • BioTech Health X
  • July 21, 2025
GlucoTrack Inc. (NASDAQ:GCTK) is a medical technology company revolutionizing diabetes management through the development of its innovative continuous…
0 Shares
0
0
0
0
0
0
0

Biotech NewsGlucoTrack (GCTK)’s Implant Could Kill Finger-Prick Testing Forever—Investors are Starting to Notice

  • BioTech Health X
  • June 25, 2025
GlucoTrack Inc. (NASDAQ:GCTK) is a pioneering medical technology company that has spent over two decades innovating diabetes management…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • 5 Best Micro Cap Healthcare Stocks to Watch Today
  • CorMedix (CRMD) Posts 157% Revenue Growth and $26M in Profit but There’s an Acquisition Twist
  • Mirum Pharmaceuticals (MIRM) Flexes 46% LIVMARLI Sales Growth
  • ADMA Biologics (ADMA) Delivers 26% ASCENIV Growth but Its Other Numbers Tell a Different Story
  • Rigel Pharmaceuticals (RIGL) Turns 14% Product Sales Growth Into a $17.3M Profit
Featured Posts
    • October 18, 2026
    5 Best Micro Cap Healthcare Stocks to Watch Today
    • October 17, 2026
    CorMedix (CRMD) Posts 157% Revenue Growth and $26M in Profit but There’s an Acquisition Twist
    • October 17, 2026
    Mirum Pharmaceuticals (MIRM) Flexes 46% LIVMARLI Sales Growth
    • October 17, 2026
    ADMA Biologics (ADMA) Delivers 26% ASCENIV Growth but Its Other Numbers Tell a Different Story
    • October 17, 2026
    Rigel Pharmaceuticals (RIGL) Turns 14% Product Sales Growth Into a $17.3M Profit
Recent Posts
  • Progyny (PGNY) Generates $50.4M in Quarterly Cash Flow
    • October 17, 2026
  • Nuvation Bio (NUVB) Posts 25% Drug Sales Growth
    • October 17, 2026
  • Top 6 Small-Cap Healthcare Stocks to Buy Right Now
    • October 17, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (6)
  • Biotech News (1,126)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top